參考文獻 |
1. Negrin, R.S., Graft-versus-host disease versus graft-versus-leukemia. Hematology 2014, the American Society of Hematology Education Program Book, 2015. 2015(1): p. 225-230.
2. Congdon, C.C., D. Uphoff, and E. Lorenz, Modification of acute irradiation injury in mice and guinea pigs by injection of bone marrow: a histopathologic study. Journal of the National Cancer Institute, 1952. 13(1): p. 73-107.
3. Lorenz, E., C. Congdon, and D. Uphoff, Modification of acute irradiation injury in mice and guinea-pigs by bone marrow injections. Radiology, 1952. 58(6): p. 863-877.
4. Billingham, R., Reactions of Graft against Their Hosts: Transplantation immunity works both ways—hosts destroy grafts and grafts may harm hosts. Science, 1959. 130(3381): p. 947-953.
5. Billingham, R.E., The biology of graft-versus-host reactions. Harvery lect., 1967. 62: p. 21-78.
6. Kernan, N.A., et al., Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. 1986.
7. Korngold, R. and J. Sprent, Purified T cell subsets and lethal graft-versus-host disease in mice. Progress in Bone Marrow Transplantation. New York: Alan R. Liss, Inc, 1987: p. 213-218.
8. Ferrara, J.L., et al., Graft-versus-host disease. The Lancet, 2009. 373(9674): p. 1550-1561.
9. Blazar, B.R., W.J. Murphy, and M. Abedi, Advances in graft-versus-host disease biology and therapy. Nature Reviews Immunology, 2012. 12(6): p. 443-458.
10. Kooy, D.v.d. and a.S. Weiss, Why Stem Cells? Science, 2000. 287(5457): p. 1439-1441.
11. Alison, M.R., et al., An introduction to stem cells. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 2002. 197(4): p. 419-423.
12. Ramalho-Santos, M. and H. Willenbring, On the Origin of the Term “Stem Cell”. Cell Stem Cell, 2007. 1(1): p. 35-38.
13. Melton, D., ‘Stemness’: definitions, criteria, and standards, in Essentials of stem cell biology. 2014, Elsevier. p. 7-17.
14. Papapetrou, E.P., et al., Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proceedings of the National Academy of Sciences, 2009. 106(31): p. 12759-12764.
15. P De Miguel, M., et al., Immunosuppressive properties of mesenchymal stem cells: advances and applications. Current molecular medicine, 2012. 12(5): p. 574-591.
16. Ding, D.C., W.C. Shyu, and S.Z. Lin, Mesenchymal stem cells. Cell Transplant, 2011. 20(1): p. 5-14.
17. Minguell, J.J., A. Erices, and P. Conget, Mesenchymal stem cells. Experimental biology and medicine, 2001. 226(6): p. 507-520.
18. Kuo, T.K., J.H. Ho, and O.K. Lee, Mesenchymal stem cell therapy for nonmusculoskeletal diseases: emerging applications. Cell Transplantation, 2009. 18(9): p. 1013-1028.
19. Oishi, K., et al., Differential ability of somatic stem cells. Cell transplantation, 2009. 18(5-6): p. 581-590.
20. Dominici, M., et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006. 8(4): p. 315-317.
21. Pittenger, M.F., et al., Multilineage potential of adult human mesenchymal stem cells. science, 1999. 284(5411): p. 143-147.
22. Schachtele, S., C. Clouser, and J. Aho, Markers and Methods to Verify Mesenchymal Stem Cell Identity. Potency, and Quality.[(accessed on 29 January 2020)].
23. Wakitani, S., T. Saito, and A.I. Caplan, Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine, 1995. 18(12): p. 1417-1426.
24. De Bari, C., et al., Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. The Journal of cell biology, 2003. 160(6): p. 909-918.
25. Ninichuk, V., et al., Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney international, 2006. 70(1): p. 121-129.
26. Black, I.B. and D. Woodbury, Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells, Molecules, and Diseases, 2001. 27(3): p. 632-636.
27. Hofstetter, C., et al., Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences, 2002. 99(4): p. 2199-2204.
28. Nauta, A.J. and W.E. Fibbe, Immunomodulatory properties of mesenchymal stromal cells. Blood, The Journal of the American Society of Hematology, 2007. 110(10): p. 3499-3506.
29. Bartholomew, A., et al., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental hematology, 2002. 30(1): p. 42-48.
30. Di Nicola, M., et al., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, The Journal of the American Society of Hematology, 2002. 99(10): p. 3838-3843.
31. Klyushnenkova, E., et al., T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. Journal of biomedical science, 2005. 12(1): p. 47-57.
32. Bernardo, M., et al., Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone marrow transplantation, 2011. 46(2): p. 200-207.
33. Aggarwal, S. and M.F. Pittenger, Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005. 105(4): p. 1815-1822.
34. Nasef, A., et al., Identification of IL-10 and TGF-β transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expression The Journal of Liver Research, 2006. 13(4-5): p. 217-226.
35. Ortiz, L.A., et al., Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences, 2007. 104(26): p. 11002-11007.
36. Lee, R.H., et al., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell stem cell, 2009. 5(1): p. 54-63.
37. Kim, J. and P. Hematti, Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages. Experimental hematology, 2009. 37(12): p. 1445-1453.
38. Djouad, F., et al., Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin‐6‐dependent mechanism. Stem cells, 2007. 25(8): p. 2025-2032.
39. Liu, Y., et al., MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6. Biochemical and Biophysical Research Communications, 2014. 450(4): p. 1409-1415.
40. Sato, K., et al., Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood, 2007. 109(1): p. 228-234.
41. Sensebe, L., et al., Mesenchymal stem cells for clinical application. Vox sanguinis, 2010. 98(2): p. 93-107.
42. Pittenger, M.F., et al., Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regenerative Medicine, 2019. 4(1): p. 22.
43. Tirode, F., et al., Mesenchymal Stem Cell Features of Ewing Tumors. Cancer Cell, 2007. 11(5): p. 421-429.
44. Phinney, D.G. and D.J. Prockop, Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views. Stem cells, 2007. 25(11): p. 2896-2902.
45. Han, Y., et al., Mesenchymal stem cells for regenerative medicine. Cells, 2019. 8(8): p. 886.
46. Young, J.L., A.W. Holle, and J.P. Spatz, Nanoscale and mechanical properties of the physiological cell-ECM microenvironment. Exp Cell Res, 2016. 343(1): p. 3-6.
47. Miller, R.T., Mechanical properties of basement membrane in health and disease. Matrix Biol, 2017. 57-58: p. 366-373.
48. Muiznieks, L.D. and F.W. Keeley, Molecular assembly and mechanical properties of the extracellular matrix: A fibrous protein perspective. Biochim Biophys Acta, 2013. 1832(7): p. 866-75.
49. Stylianopoulos, T., et al., Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions. Biophys J, 2010. 99(5): p. 1342-9.
50. Mecham, R.P., Overview of extracellular matrix. Curr Protoc Cell Biol, 2001. Chapter 10: p. Unit 10.1.
51. Hussey, G.S., J.L. Dziki, and S.F. Badylak, Extracellular matrix-based materials for regenerative medicine. Nature Reviews Materials, 2018. 3(7): p. 159-173.
52. Méhes, E., et al., Matrigel patterning reflects multicellular contractility. PLoS Comput Biol, 2019. 15(10): p. e1007431.
53. Hughes, C.S., L.M. Postovit, and G.A. Lajoie, Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics, 2010. 10(9): p. 1886-90.
54. Parenteau-Bareil, R., R. Gauvin, and F. Berthod, Collagen-Based Biomaterials for Tissue Engineering Applications. Materials, 2010. 3(3): p. 1863-1887.
55. Malinda, K.M. and H.K. Kleinman, The laminins. Int J Biochem Cell Biol, 1996. 28(9): p. 957-9.
56. Colognato, H. and P.D. Yurchenco, Form and function: the laminin family of heterotrimers. Dev Dyn, 2000. 218(2): p. 213-34.
57. Arimori, T., et al., Structural mechanism of laminin recognition by integrin. Nature Communications, 2021. 12(1): p. 4012.
58. Tanzer, M.L., et al., Role of laminin carbohydrates on cellular interactions. Kidney Int, 1993. 43(1): p. 66-72.
59. Sato, F., et al., Apigenin Induces Morphological Differentiation and G2-M Arrest in Rat Neuronal Cells. Biochemical and Biophysical Research Communications, 1994. 204(2): p. 578-584.
60. Yan, H.H., et al., Ectoplasmic specialization: a friend or a foe of spermatogenesis? Bioessays, 2007. 29(1): p. 36-48.
61. Tang, J. and T. Saito, A Novel Fragment Derived from Laminin-411 Facilitates Proliferation and Differentiation of Odontoblast-Like Cells. Biomed Res Int, 2018. 2018: p. 9465383.
62. Tang, J. and T. Saito, iMatrix-511 Stimulates the Proliferation and Differentiation of MDPC-23 Cells into Odontoblastlike Phenotype. J Endod, 2018. 44(9): p. 1367-1375.
63. Colognato, H. and P.D. Yurchenco, Form and function: the laminin family of heterotrimers. Developmental dynamics: an official publication of the American Association of Anatomists, 2000. 218(2): p. 213-234.
64. Braam, S.R., et al., Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells, 2008. 26(9): p. 2257-65.
65. Chen, G., et al., Chemically defined conditions for human iPSC derivation and culture. Nature methods, 2011. 8(5): p. 424-429.
66. Sato, K., et al., Vitronectin binding protein, BOM1093, confers serum resistance on Borrelia miyamotoi. Sci Rep, 2021. 11(1): p. 5462.
67. Kleiveland, C.R., Peripheral blood mononuclear cells. The impact of food bioactives on health, 2015: p. 161-167.
68. Barbedo, J.G.A. Automatic object counting in Neubauer chambers. in Embrapa Informática Agropecuária-Artigo em anais de congresso (ALICE). 2013. In: SIMPÓSIO BRASILEIRO DE TELECOMUNICAÇÕES, 31., 2013, Fortaleza.[Anais ….
69. Jaatinen, T. and J. Laine, Isolation of mononuclear cells from human cord blood by Ficoll‐Paque density gradient. Current protocols in stem cell biology, 2007. 1(1): p. 2A. 1.1-2A. 1.4.
70. Roberts, S.J., et al., Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells. Stem Cell Research, 2011. 7(2): p. 137-144.
71. Wrobel, E., J. Leszczynska, and E. Brzoska, The Characteristics Of Human Bone-Derived Cells (HBDCS) during osteogenesis in vitro. Cellular & Molecular Biology Letters, 2016. 21(1): p. 26.
72. Kubista, M., et al., Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene, 2002. 21(31): p. 4747-4756.
73. Zuk, P.A., et al., Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell, 2002. 13(12): p. 4279-4295.
74. Huang, Y.-R., Design of Thermoresponsive Surface Immobilized with ECM for Differentiation of Human Amniotic Fluid Stem Cells. 2019.
75. Vierck, J.L., et al., Ten commandments for preventing contamination of primary cell cultures. Methods in cell science, 2000. 22(1): p. 33-41.
76. Sharma, M.B., L.S. Limaye, and V.P. Kale, Mimicking the functional hematopoietic stem cell niche in vitro: recapitulation of marrow physiology by hydrogel-based three-dimensional cultures of mesenchymal stromal cells. Haematologica, 2012. 97(5): p. 651.
77. Bunnell, B.A., A.M. Betancourt, and D.E. Sullivan, New concepts on the immune modulation mediated by mesenchymal stem cells. Stem cell research & therapy, 2010. 1(5): p. 1-8.
78. Van Der Sanden, B., et al., Optimizing stem cell culture. Journal of cellular biochemistry, 2010. 111(4): p. 801-807.
79. Gattazzo, F., A. Urciuolo, and P. Bonaldo, Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochimica et Biophysica Acta (BBA)-General Subjects, 2014. 1840(8): p. 2506-2519.
80. Page-McCaw, A., A.J. Ewald, and Z. Werb, Matrix metalloproteinases and the regulation of tissue remodelling. Nature reviews Molecular cell biology, 2007. 8(3): p. 221-233.
81. Lu, P., et al., Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor perspectives in biology, 2011. 3(12): p. a005058.
82. Jiang, W. and J. Xu, Immune modulation by mesenchymal stem cells. Cell proliferation, 2020. 53(1): p. e12712.
83. Rasmusson, I., Immune modulation by mesenchymal stem cells. Experimental cell research, 2006. 312(12): p. 2169-2179.
84. Le Blanc, K., Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy, 2006. 8(6): p. 559-561. |